Jyothy Labs Limited

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a conference call scheduled for November 4, 2026, to discuss its un-audited financial results for the quarter and half year ended September 30, 2026.

Jyothy Labs Limited

Jyothy Labs Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 30, 2026.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange regarding the allotment of 21,009 shares under the Restricted Stock Unit Plan 2023.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange regarding 'Update on fire incident at C&FA operated warehouse'. The insurance claim of the Company has been settled by the Insurance Company and the Company has received the insurance claim amount.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window to deal in the Company's shares is closed for designated persons from October 1, 2026, till the end of forty eight hours of the date of making the financial results public.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about the reaffirmation of its long-term bank facilities credit rating by CARE Ratings Limited (CARE) at CARE AA with a stable outlook.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on September 25, 2026, with Pari Washington Company Advisors Pvt Ltd, and has stated that no unpublished price sensitive information will be shared during the meeting.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on September 23, 2026, with Nalanda Capital, where no unpublished price sensitive information will be shared.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on September 18, 2026, which will be attended by the company's representatives. The meeting is not expected to share any unpublished price-sensitive information.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on September 17, 2026, to be attended by the company's representatives. The meeting will be with Canara Robeco Mutual Fund, and no unpublished price-sensitive information (UPSI) will be shared.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on September 16, 2026, to be attended by the company's representatives. No unpublished price-sensitive information is proposed to be shared during the meeting.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on September 11, 2026, where no unpublished price sensitive information will be shared.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on September 10, 2026, which will be attended by the company's representatives. No Unpublished Price Sensitive Information (UPSI) is proposed to be shared during the meeting.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about Options to purchase securities under Employee Stock Unit Plan 2023. The company has approved the grant of 1,46,141 Restricted Stock Units exercisable into 1,46,141 equity shares of the Company of face value of Re. 1/- each fully paid-up to selected employees of the Company. The RSUs shall vest after the minimum vesting period of 1 (one) year but not later than the maximum period of 4 (four) years from the date of grant of RSUs subject to fulfillment of performance conditions.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on September 8, 2026, which will be attended by the company's representatives. The meeting is one-on-one with Asit C. Mehta Investment Intermediates Ltd, and no unpublished price sensitive information will be shared.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on September 8, 2026, with V.E.C Investment Management (India) Private Limited, and has stated that no Unpublished Price Sensitive Information (UPSI) will be shared during the meeting.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about General Updates, stating that NSE Sustainability Ratings & Analytics Limited has assigned an Environmental, Social, and Governance (ESG) rating of '67' to the Company based on the data pertaining to FY 2025-26.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on September 3, 2026, to be attended by the company's representatives. The meeting is a one-on-one session with ICICI Securities. No unpublished price-sensitive information (UPSI) is proposed to be shared during the meeting.

Jyothy Labs Limited

Jyothy Labs Limited has received an Excise Duty Order from the Commissionerate of Central Goods and Services Tax for a period from April 2016 to June 2017, resulting in a demand of Rs. 9.69 crore, including penalty and interest, due to a difference in interpretation of HSN classification of the product manufactured. The company does not foresee any material impact on its financials, operations, or other activities.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about the transcript of the earnings conference call for the quarter ended June 30, 2026. The company discussed the impact of crude oil and crude-linked derivatives volatility on input costs, packaging materials, and supply chain planning. They expect double-digit revenue growth for FY27, excluding the Pril business, and margin recovery over the coming quarters.